OTC:ACOGF

Alpha Cognition - ACOGF Stock Forecast, Price & News

C$0.31

0.00 (0.00%)

(As of 01/27/2023 12:00 AM ET)

Add

Compare

Today's Range: C$0.31
▼
C$0.31
50-Day Range: C$0.15
▼
C$0.35
52-Week Range: C$0.15
▼
C$1.08

Volume: 100 shs
Average Volume: 3,222 shs
Market Capitalization: C$19.20 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: C$3.00

About Alpha Cognition (OTC:ACOGF) Stock

Alpha Cognition Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for Alzheimer's disease and amyotrophic lateral sclerosis (ALS). It develops ALPHA-1062, an acetylcholine esterase inhibitor for the treatment of dementia of the Alzheimer's type and mild traumatic brain injury; and ALPHA-0602, a gene therapy for the treatment of ALS. The company was formerly known as Crystal Bridge Enterprises Inc. and changed its name to Alpha Cognition Inc. in March 2021. Alpha Cognition Inc. was founded in 2000 and is headquartered in Vancouver, Canada.

Receive ACOGF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alpha Cognition and its competitors with MarketBeat's FREE daily newsletter.

ACOGF Stock News Headlines

October 18, 2022 | finance.yahoo.com

ACOGF: Bioequivalence Complete

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive ACOGF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alpha Cognition and its competitors with MarketBeat's FREE daily newsletter.

ACOGF Company Calendar

Today: 1/28/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTC
Industry: N/A
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTC:ACOGF
CUSIP: N/A
CIK: N/A
Web: www.alphacognition.com
Phone: 604-564-9244
Fax: N/A
Employees: N/A
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: C$3.00
High Stock Price Forecast: C$3.00
Low Stock Price Forecast: C$3.00
Forecasted Upside/Downside: +853.3%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): C($0.20)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: C$-19,550,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -167.43%
Return on Assets: -110.39%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 3.08
Quick Ratio: 3.08

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: C$0.20 per share
Price / Book: 1.57

Miscellaneous

Outstanding Shares: 61,020,000
Free Float: 41,789,000
Market Cap: C$19.20 million
Optionable: Not Optionable
Beta: 2.46

Key Executives

Mr. Michael E. McFadden (Age 56)
CEO & Director
Comp: $429.78k

Mr. Kenneth Anthony Cawkell B.A. (Age 72)
LL.B., Founder, Special Advisor, Corp. Sec. & Director
Comp: $264.6k

Dr. Denis G. Kay Ph.D. (Age 66)
Chief Scientific Officer
Comp: $238.57k

Ms. Lauren D'Angelo M.B.A.
Chief Commercial Officer

Mr. Donald A. Kalkofen B.A. (Age 59)
Chief Financial Officer

Ms. Colleen Johns
Sr. VP of Product Devel.

Dr. Cedric O'Gorman M.B.A. (Age 48)
M.D., MBA, Chief Medical Officer

Key Competitors

View All Competitors

ACOGF Stock - Frequently Asked Questions

Should I buy or sell Alpha Cognition stock right now?: 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Alpha Cognition in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" ACOGF shares.
View ACOGF analyst ratings or view top-rated stocks.
What is Alpha Cognition's stock price forecast for 2023?: 1 brokers have issued 1 year target prices for Alpha Cognition's stock. Their ACOGF share price forecasts range from C$3.00 to C$3.00. On average, they expect the company's stock price to reach C$3.00 in the next twelve months. This suggests a possible upside of 853.3% from the stock's current price.
View analysts price targets for ACOGF or view top-rated stocks among Wall Street analysts.
How have ACOGF shares performed in 2023?: Alpha Cognition's stock was trading at C$0.21 at the beginning of 2023. Since then, ACOGF shares have increased by 47.3% and is now trading at C$0.31.
View the best growth stocks for 2023 here.

What is Alpha Cognition's stock symbol?: Alpha Cognition trades on the OTC under the ticker symbol "ACOGF."
How do I buy shares of Alpha Cognition?: Shares of ACOGF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Alpha Cognition's stock price today?: One share of ACOGF stock can currently be purchased for approximately C$0.31.
How much money does Alpha Cognition make?: Alpha Cognition (OTC:ACOGF) has a market capitalization of C$19.20 million. The company earns C$-19,550,000.00 in net income (profit) each year or C($0.20) on an earnings per share basis.
How can I contact Alpha Cognition?: Alpha Cognition's mailing address is 1228 Hamilton Street Suite 301, Vancouver BC, V6B 6L2. The official website for the company is www.alphacognition.com. The company can be reached via phone at 604-564-9244 or via email at stefan@bristolir.com.

This page (OTC:ACOGF) was last updated on 1/28/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial